Check out this short documentary about how ground-breaking research from VIB / KU Leuven, the VIB Discovery Sciences Team, and VIB/ UZ Leuven, is successfully translated by Augustine Therapeutics into a cure for Charcot-Marie-Tooth disease, a hereditary progressive neuropathic disorder affecting about 3 million people worldwide.

It features an interview with prof. Ludo Van Den Bosch, prof. Philip Van Damme and Dr. Frederik Rombouts, Head of Medicinal Chemistry at Augustine Therapeutics, are currently developing a safe and effective drug based on the VIB discoveries.

We sincerely thank Kanaal Z - Canal Z for featuring this exceptional academic-industry partnership toward a potential cure for Charcot-Marie-Tooth disease.